The Accuracy of Transit Time Flow Measurement in Predicting Graft Patency after Coronary Artery Bypass Grafting
Authors:
- 1 November 2013
- journal article
- research article
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 8 (6) , 416-419
Abstract
Objective: Transit time flow measurement (TTFM) is a method used to assess intraoperative blood flow after vascular anastomoses. Angiography represents the criterion standard for the assessment of graft patency after coronary artery bypass grafting (CABG). The purpose of this study was to compare flow measurements from TTFM to diagnostic angiography. Methods: From October 9, 2009, to April 30, 2012, a total of 259 patients underwent robotic-assisted CABG procedures at a single institution. Of these, 160 patients had both TTFM and either intraoperative or postoperative angiography of the left internal mammary artery to the left anterior descending coronary artery graft. Transit time flow measurements were obtained after completion of the anastomosis and after administration of protamine before chest closure. Transit time flow measurement assessment included pulsatility index, diastolic fraction, and flow (milliliters per minute). Angiograms were graded according to the Fitzgibbon criteria. The patients were grouped according to angiographic findings, with perfect grafts defined as FitzGibbon A and problematic grafts defined as either Fitzgibbon B or O. Results: Overall, there were 152 (95%) of 160 angiographically perfect grafts (FitzGibbon A). Of the eight problematic grafts, five were occluded (Fitzgibbon O) and three had significant flow-limiting lesions (FitzGibbon B). Two patients had intraoperative graft revision after completion angiography, one had redo CABG during the same hospitalization, and five were treated with percutaneous coronary intervention. A significant difference was seen in mean ± SD flow (34.3 ± 16.8 mL/min vs 23.9 ± 12.5 mL/min, P = 0.033) between patent and nonpatent grafts but not in pulsatility index (1.98 ± 0.76 vs 1.65 ± 0.48, P = 0.16) or diastolic fraction (73.5% ± 8.45% vs 70.9% ± 6.15%, P = 0.13). Conclusions: Although TTFM can be a useful tool for graft assessment after CABG, false negatives can occur. Angiography remains the criterion standard to assess graft patency and quality of the anastomosis after CABG.Keywords
This publication has 12 references indexed in Scilit:
- Intraoperative Fluorescence Imaging after Transit-Time Flow Measurement during Coronary Artery Bypass GraftingInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2012
- Lessons Learned from Robotic-Assisted Coronary Artery Bypass Surgery: Risk Factors for Conversion to Median SternotomyInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2012
- Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts☆European Journal of Cardio-Thoracic Surgery, 2010
- Routine Intraoperative Completion Angiography After Coronary Artery Bypass Grafting and 1-Stop Hybrid RevascularizationJACC, 2009
- Intraoperative coronary graft assessmentCurrent Opinion in Cardiology, 2008
- The impact of intraoperative transit time flow measurement on the results of on-pump coronary surgeryEuropean Journal of Cardio-Thoracic Surgery, 2007
- A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass graftsThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Predictive value of intraoperative transit-time flow measurement for short-term graft patency in coronary surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Prediction of Graft Flow Impairment by Intraoperative Transit Time Flow Measurement in Off-Pump Coronary Artery Bypass Using Arterial GraftsThe Annals of Thoracic Surgery, 2005
- Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 yearsJACC, 1996